Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 7))	677,890	312,117
Depreciation	436	436
Research and development (including stock-based compensation (Note 7))	169,721	106,746
Total operating expenses	848,047	419,299
Loss from operations	(848,047)	(419,299)
Other expense:
Interest expense	92,496	98,439
Total other expense	92,496	98,439
Net loss	(940,543)	(517,738)
Net loss attributable to the noncontrolling interest	3,169	507
Net loss applicable to Bion's common stockholders	$ (937,374)	$ (517,231)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.04)	$ (0.02)
Weighted-average number of common shares outstanding:
Basic and diluted (in shares)	25,659,730	24,067,093